Search companies or stocks...
ABBVAbbVie Inc.
At close · 11 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune…
Current stock price of AbbVie Inc. (ABBV) stock is $257.06. The stock price is +0.81% higher in the session. The intraday range can be seen from this page. Volume of AbbVie Inc. (ABBV) stock is 4.30M.
Last updated at 11 Sept 2026, 08:00 pm.
The stock price of AbbVie Inc. (ABBV) can change with earnings, company news, and overall market sentiment. AbbVie Inc. operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether AbbVie Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ABBV on this page is 25.23. EPS on this page is 10.19. Compare those figures with peers and growth expectations before deciding if the current AbbVie Inc. price is justified.
Historical performance for AbbVie Inc. (ABBV) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ABBV reacted to past earnings and market events.
Buying AbbVie Inc. (ABBV) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
